MAPT and Alzheimer disease: Human brain Tau is shown to be O-GlcNAcylated [62], which negatively regulates tau phosphorylation [133], and interestingly, in a starved mouse model that mimics AD phenotypes, Tau phosphorylation was increased and Tau O-GlcNAcylation was decreased via low glucose uptake or metabolism [127].